AAAAAA

   
Results: 1-12 |
Results: 12

Authors: ANTHONY MT ZEIGLER ZR LISTER J RAYMOND JM SHADDUCK RK KRAMER RE GRYN JF RINTELS PB BESA EC GEORGE JN SILVER B JOYCE R BODENSTEINER D
Citation: Mt. Anthony et al., PLASMINOGEN-ACTIVATOR INHIBITOR (PAI-1) ANTIGEN LEVELS IN PRIMARY TTPAND SECONDARY TTP POST-BONE MARROW TRANSPLANTATION, American journal of hematology, 59(1), 1998, pp. 9-14

Authors: GRIGSBY J KRAMER RE SCHNEIDERS JL GATES JR SMITH WB
Citation: J. Grigsby et al., PREDICTING OUTCOME OF ANTERIOR TEMPORAL LOBECTOMY USING SIMULATED NEURAL NETWORKS, Epilepsia, 39(1), 1998, pp. 61-66

Authors: ZEIGLER ZR ROSENFELD CS ANDREWS DF NEMUNAITIS J RAYMOND JM SHADDUCK RK KRAMER RE GRYN JF RINTELS PB BESA EC GEORGE JN
Citation: Zr. Zeigler et al., PLASMA VON-WILLEBRAND-FACTOR ANTIGEN (VWF-AG) AND THROMBOMODULIN (TM)LEVELS IN ADULT THROMBOTIC THROMBOCYTOPENIC PURPURA HEMOLYTIC-UREMIC SYNDROMES (TTP HUS) AND BONE-MARROW TRANSPLANT-ASSOCIATED THROMBOTIC MICROANGIOPATHY (BMT-TM)/, American journal of hematology, 53(4), 1996, pp. 213-220

Authors: BOUCHER BA FELER CA DEAN C MICHIE DD TIPTON BK SMITH KR KRAMER RE YOUNG B PARKS BR KUGLER AR
Citation: Ba. Boucher et al., THE SAFETY, TOLERABILITY, AND PHARMACOKINETICS OF FOSPHENYTOIN AFTER INTRAMUSCULAR AND INTRAVENOUS ADMINISTRATION IN NEUROSURGERY PATIENTS, Pharmacotherapy, 16(4), 1996, pp. 638-645

Authors: KRAMER RE
Citation: Re. Kramer, TRIBUTE TO DOW,ROBERT,S., MD, PHD, Neurology, 47(2), 1996, pp. 611-612

Authors: KRAMER RE BREWER J LOCKFIELD J BRACHT KA
Citation: Re. Kramer et al., POLYSOMNOGRAPHIC FINDINGS IN PATIENTS WITH QUADRIPLEGIA - CORRELATIONS WITH LEVEL OF SPINAL-CORD INJURY, Neurology, 45(4), 1995, pp. 286-286

Authors: GRIGSBY J KRAMER RE SCHNEIDERS JL SMITH WB GATES JR
Citation: J. Grigsby et al., PREDICTING OUTCOME OF EPILEPSY SURGERY WITH SIMULATED NEURAL NETWORKS, Epilepsia, 36, 1995, pp. 364-364

Authors: KRAMER RE
Citation: Re. Kramer, RETIRING OR RECHARGING - COMMENTS, UPDATES ON THE SHAPIRO,LEONARDO LIFE AND PLANS, TDR, 38(1), 1994, pp. 37-38

Authors: KRAMER RE
Citation: Re. Kramer, THE NEAS LOOPY LOGIC - COMMENT, TDR, 37(4), 1993, pp. 9-10

Authors: KRAMER RE
Citation: Re. Kramer, SHAPIRO AND SHALIKO -COMPANY - TECHNIQUES OF TESTIMONY( SHAPIRO,LEONARDO, FOUNDER OF SHALIKO), TDR, 37(4), 1993, pp. 65-100

Authors: MATSUO F BERGEN D FAUGHT E MESSENHEIMER JA DREN AT RUDD GD LINEBERRY CG MADSEN JA RISTANOVIC R ERENBERG G KRAMER RE HARNER RN SCHOMER DL LEPPIK I COLLINS SD KING KW SHAMSNIA M WHITE RL GAY PE ROTHNER AD DRAKE ME DETOLEDO J SUSSMAN NM MIKATI MA OLSON D FROMM G MURRO AM EHLE A FOLEY JF MORRIS HH SMITH DB SO EL SCHACHTER SC KUZNIECKY R LAXER K GALLAGHER BB WEISBERG LA MOORE EL
Citation: F. Matsuo et al., PLACEBO-CONTROLLED STUDY OF THE EFFICACY AND SAFETY OF LAMOTRIGINE INPATIENTS WITH PARTIAL SEIZURES, Neurology, 43(11), 1993, pp. 2284-2291

Authors: KRAMER RE
Citation: Re. Kramer, EFFECTS OF DILTIAZEM ON CALCIUM-METABOLISM IN CULTURED BOVINE GLOMERULOSA CELLS - RELATIONSHIPS TO THE ACTIONS OF ANGIOTENSIN-II AND POTASSIUM, The Journal of pharmacology and experimental therapeutics, 266(1), 1993, pp. 374-384
Risultati: 1-12 |